| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2023 | Oct 27, 2023 | Tourmaline Bio, Inc. | Director | Buy | 85.0 | +20,000 | 2.10% | ✗ | $280.6K |
| Aug 26, 2021 | Aug 30, 2021 | Whitehawk Therapeutics, Inc. | Director | Buy | 100.0 | +259,998 | 1320.19% | ✗ | $3.4M |
| Mar 15, 2017 | Mar 17, 2017 | Whitehawk Therapeutics, Inc. | Director | Buy | 100.0 | +400,000 | 33.02% | ✗ | $2M |